Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.301
+0.018 (6.33%)
At close: Jun 26, 2026, 4:00 PM EDT
0.315
+0.014 (4.69%)
Pre-market: Jun 29, 2026, 8:37 AM EDT
Ensysce Biosciences Employees
As of December 31, 2025, Ensysce Biosciences had 10 total employees, including 8 full-time and 2 part-time employees. The number of employees increased by 2 or 25.00% compared to the previous year.
Employees
10
Change (1Y)
2
Growth (1Y)
25.00%
Revenue / Employee
$470,788
Profits / Employee
-$1,178,654
Market Cap
4.42M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| CollPlant Biotechnologies | 39 |
| GeoVax Labs | 19 |
| FibroBiologics | 15 |
| TransCode Therapeutics | 12 |
| Artelo Biosciences | 7 |
| Alzamend Neuro | 6 |
| Creative Medical Technology Holdings | 4 |
ENSC News
- 3 days ago - Ensysce Biosciences enrolls first patient in final stage of PF614-MPAR-102 - TheFly
- 3 days ago - Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study - Accesswire
- 24 days ago - Ensysce Biosciences files to sell 1.3M shares of common stock for holders - TheFly
- 25 days ago - Ensysce Biosciences Registration statement: Registration filing - Filings
- 6 weeks ago - Ensysce Biosciences Reports First Quarter 2026 Financial Results - Accesswire
- 6 weeks ago - Ensysce Biosciences Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Ensysce Biosciences Earnings release: Q1 2026 - Filings
- 6 weeks ago - Ensysce announces expansion of patent protection for MPAR technology - TheFly